Urinary Bladder Neoplasms: all 1,649 studies
Page 9 of 17. Open to participants first (427), then studies with results posted, then the rest; newest registration first within each.
- Antegrade Observational Comparative Study for the Intravesical Instillation Therapy of Bacillus Calmette Guerin With the Use of Different Types of Urinary Catheters in Patients With Urinary Bladder CancerCompletedNCT05675176
- Gemcitabine and Docetaxel Therapy in High-risk BCG-naive Patients With Non-muscle Invasive Bladder CancerActive, not recruitingNCT05671900Not applicable
- Urine VOC Investigation in Bladder Cancer DiagnosisCompletedNCT05671289
- Obturator Block in Lateral Tumors of the Bladder: Does it Have Adverse Effects on Early Postoperative Mobilization?Status unknownNCT05652309
- Intravesical Gem/Doce in Patients With NMIBCActive, not recruitingNCT05644041Phase 2
- Bladder Washing Cytology for Detection of Urothelial Carcinoma Using Catheter or Flexible Cystoscope: Which is Better?Status unknownNCT05643807Not applicable
- Urine Sample Collection for Validation of the AnchorDx UriFind™ Bladder Cancer AssaySuspendedNCT05643690
- ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality TherapyCompletedNCT05630131
- Narrow-band Imaging Diagnostic Classification System for Bladder TumorsStatus unknownNCT05611762
- CLEAR Care Companion ApplicationCompletedNCT05578898Not applicable
- A Study of Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial CancerTerminatedNCT05568407
- A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder CancerActive, not recruitingNCT05567185Phase 1
- Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder CancerStatus unknownNCT05564897Phase 2
- Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA TrialWithdrawnNCT05564416Phase 2
- 89Zr-girentuximab for PET Imaging of CAIX Positive Solid TumorsTerminatedNCT05563272Phase 2
- An Open, Dose-escalation Clinical Study of Chimeric Exosomal Tumor Vaccines for Recurrent or Metastatic Bladder CancerStatus unknownNCT05559177Early Phase 1
- Blue Laser -5ala Photodynamic Therapy (PDT) in High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) PatientsStatus unknownNCT05547516Not applicable
- Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene AlterationsActive, not recruitingNCT05544552Phase 1/2
- Comparison of Interfascial Injection Versus Subpectineal Injection on Ultrasound-guided Obturator Nerve BlockCompletedNCT05540847Not applicable
- Pembrolizumab-Sacituzumab Govitecan Combination to Treat High-risk, Localized Bladder CancerActive, not recruitingNCT05535218Phase 2
- Risk-stratification Based Bladder-sparing Modalities for Muscle-invasive Bladder CancerActive, not recruitingNCT05531123Phase 2
- A Study of Evorpacept (ALX148) With Enfortumab Vedotin for Subjects With Urothelial Carcinoma (ASPEN-07)CompletedNCT05524545Phase 1
- Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)Active, not recruitingNCT05520099
- A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder CancerStatus unknownNCT05508568
- A Proposed Tetra-modal Treatment Protocol for Muscle Invasive Urothelial Carcinoma of the Urinary BladderStatus unknownNCT05503563
- A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder CancerActive, not recruitingNCT05483868Phase 1
- Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)CompletedNCT05461430
- SOX2 & PDL1 Expression on Urinary Bladder CarcinomaStatus unknownNCT05429710
- Tilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable: a Multi-center StudyStatus unknownNCT05418309Phase 2
- Evaluating Sexual Function in Women Undergoing a Radical Cystectomy for Bladder CancerCompletedNCT05399004
- FL- 101 Study in Non-Metastatic MIBCWithdrawnNCT05395260Early Phase 1
- A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Urological Tumors and Other Solid TumorsActive, not recruitingNCT05393427Phase 1
- Multicentral Preventive Antibiotics With Cystectomy Within Enhanced Recovery After SurgeryStatus unknownNCT05392634Phase 3
- Effect of Fresh Gas Flow on Emergence TimeCompletedNCT05376631Not applicable
- A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)CompletedNCT05375903Phase 1
- A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid TumoursTerminatedNCT05363605Phase 1/2
- Novel Urine-Based DNA Methylation Biomarkers for Urothelial Bladder Carcinoma Detection in Patients With HematuriaCompletedNCT05362539Not applicable
- A Diagnostic for the Early Detection of Bladder CancerActive, not recruitingNCT05347342
- Validation Study of Uromonitor in High Risk Microhematuria PatientsStatus unknownNCT05344937
- Longitudinal Geriatric Assessment to Optimize Outcomes of Older Patients With Muscle-Invasive Bladder Cancer After Radical CystectomyWithdrawnNCT05335707
- Machine Learning-Based Prediction of BCG Response in High-Risk Non-Muscle Invasive Bladder Cancer PatientsStatus unknownNCT05332353
- Sensitivity of Multiparametric MRI in Differentiation Between Muscle Invasive and Non-muscle Invasive Urinary Bladder CancerCompletedNCT05324033
- RADIO FREQUENCY ABLATION IN UNRESECTABLE MALIGNANT BILIARY OBSTRUCTIONStatus unknownNCT05320328
- Anticoagulant/Antiaggregant Use and Postoperative Bleeding Risk in Patients With Bladder Tumor and Benign Prostatic HyperplasiaCompletedNCT05314582
- High-power Green-light Laser Endoscopic Submucosal Dissection for Non-muscle-invasive Bladder CancerCompletedNCT05290623
- 3 Ultrasound Guided Plane Blocks for Perioperative Analgesia in Patients Undergoing Radical CystectomyCompletedNCT05278598Not applicable
- Confocal Laser Endomicroscopy During TransUrethral Resection for Improving BC Diagnosis and TreatmentCompletedNCT05273593Not applicable
- Opioid Free Anesthesia in Prolonged SurgeryStatus unknownNCT05262166Not applicable
- Mapping 3D BladderWithdrawnNCT05260788
- PF-07225570 Alone or in Combination With an Anti-PD-1 Antibody in Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)WithdrawnNCT05259397Phase 1
- Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder CancerActive, not recruitingNCT05241340Phase 2
- Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract CancerCompletedNCT05239169Phase 2
- To Better Understand the Most Important Factors for Patients When They Decide on the Type of Treatment They Receive for Muscle Invasive Bladder Cancer (MIBC).Status unknownNCT05236218
- Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid TumorsStatus unknownNCT05235607Phase 1
- A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.CompletedNCT05230186
- Clinical Performance Evaluation of the C2i-TestTerminatedNCT05221827
- A Study of Probiotics Administration in the Immunotherapy of Urothelial Bladder CarcinomaStatus unknownNCT05220124Phase 4
- Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UCActive, not recruitingNCT05200988Phase 2
- Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical StudyStatus unknownNCT05180851Early Phase 1
- Can Four Weeks-check Cystoscopy and Urine Cytology After Primary Complete Resection of T1 Bladder Cancer Replace Repeat Biopsy?Status unknownNCT05167916Not applicable
- RESECT: Improving Quality in TURBT Surgery.CompletedNCT05154084
- Study of Combined VisioCyt Test and FGFR3 Mutations on a Urinary Sample to Diagnose Bladder TumorsCompletedNCT05151341Not applicable
- Active Surveillance vs in Office Fulguration for Low Grade Bladder Cancer TumorsStatus unknownNCT05148728Not applicable
- Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled TrialStatus unknownNCT05146635Not applicable
- A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the BladderActive, not recruitingNCT05137262Phase 2
- Smurf2 Gene Expression in Urinary Tract TumorsStatus unknownNCT05134623
- In Vivo Proof-of-principle Study of Raman Spectroscopy in Trial Participants With Bladder TumoursStatus unknownNCT05124106Phase 1
- Validation of VI-RADS for the Detection of Detrusor Muscle InvasionStatus unknownNCT05123404Not applicable
- A Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)TerminatedNCT05121948Phase 1
- Trial of Local Cystoscopic Injection of Tremelimumab Plus Systemic Durvalumab for High Risk Non-Muscle Invasive Bladder CancerWithdrawnNCT05120622Phase 1/2
- Does Timing of Completion Radical Cholecystectomy Determine the Survival in Incidental Carcinoma GallbladderCompletedNCT05114369
- The Performance of Cancer Risk Genes in the Necessity of Secondary TURBTStatus unknownNCT05112523
- Decision Making for Urinary Diversion in Patients With Bladder CancerCompletedNCT05111639
- Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer CellsStatus unknownNCT05108077Phase 1/2
- Clinical Utility of VI-RADS in Diagnosis of MIBCStatus unknownNCT05097404
- Role of Diffusion -Weighted MRI in Evaluation of Urinary Bladder MassesStatus unknownNCT05097105
- The Application Value of Artificial Intelligence in MRI Precision Diagnosis and Treatment of Bladder CancerStatus unknownNCT05096533
- Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV StudyActive, not recruitingNCT05092958Phase 3
- Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1b)CompletedNCT05085990Phase 1
- Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1a)CompletedNCT05085977Phase 1
- Comparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin InstillationStatus unknownNCT05084586Not applicable
- Outcome of Treating Bladder Cancer in Sohag University HospitalCompletedNCT05082818
- Intravesical Prostatic Protrusion Mimicking Urothelial Cell Carcinoma of the BladderStatus unknownNCT05077852
- Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly PatientsStatus unknownNCT05068180Phase 4
- A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid TumoursActive, not recruitingNCT05057013Phase 1/2
- Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)Active, not recruitingNCT05056077Not applicable
- A Window of Opportunity Phase I Study of UGN-201 in Patients With Bladder Cancer Undergoing Radical Cystectomy Protocol #: 2021-0630Active, not recruitingNCT05055050Phase 1
- Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving ErdafitinibTerminatedNCT05052372
- AURORAX-0093A: Glycosaminoglycan Profiling for Prognostication of Muscle-invasive Bladder Cancer - a Pilot StudyCompletedNCT05028660
- En Bloc TURBT With Collins Loop vs Conventional TURBTStatus unknownNCT05027412Not applicable
- Ask Questions (ASQ):Implementation of a Communication InterventionCompletedNCT05025748Not applicable
- Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived OrganoidsActive, not recruitingNCT05024734Phase 2
- Preventing Catheter Related Bladder Discomfort (CRBD) With Bilateral Pudendal Nerve BlockStatus unknownNCT05022160Early Phase 1
- Nerve Sparing Versus Non Nerve Sparing Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder for Bladder Cancer in the MaleStatus unknownNCT05018429
- A Clinical Study of RC48-ADC Combined With Triplizumab For Treatment of Myometrial Invasive Bladder CancerStatus unknownNCT05016973Phase 2
- A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)TerminatedNCT05014139Phase 1
- Effect of Pelvic Radiotherapy on the Intestinal Microbiome and MetabolomeCompletedNCT04995809
- Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsWithdrawnNCT04985357
- Phase I BLASST-3 TrialWithdrawnNCT04972253Phase 1
- Effect and Prognosis of Immunohistochemical Biomarkers Changes in Patients With Bladder Cancer After Neoadjuvant ChemotherapyStatus unknownNCT04966975